Subscribe

Editorial

DOI: 10.4244/EIJ-E-24-00037

Beyond residual stenosis: morphofunctional assessment following primary PCI in acute coronary syndrome

Shengxian Tu1,2, PhD; Jelmer Westra3, MD, PhD

The role of wire-based physiology to guide and evaluate revascularisation in acute coronary syndrome (ACS) is still heavily debated. While fractional flow reserve (FFR)-guided complete revascularisation is superior to culprit-only revascularisation, multiple studies have recently failed to show an advantage of FFR-guided complete revascularisation over angiography-guided complete revascularisation1. The conflicting evidence underlying pressure-based assessment in ACS may be related to acute and temporary disturbances in the microcirculation. Image-derived physiology has the theoretical advantage of being less affected by microvascular involvement in the acute setting of ACS. Indeed, quantitative flow ratio (QFR) was largely unchanged for paired measurements in non-culprit lesions measured during primary percutaneous coronary intervention (PCI) or in a staged setting2. Furthermore, initial reports have documented the prognostic value of post-PCI QFR in ACS patients3. In addition to physiological lesion assessment, high-risk plaque features in non-culprit lesions that are not flow limiting (FFR>0.80) are associated with worse clinical outcome4. Hence, there may exist a complementary value of physiology and morphology for risk stratification.

In this issue of EuroIntervention, Osumi et al assessed the prognostic impact of combined post-PCI QFR and OCT in culprit vessels immediately after primary PCI5. The authors retrospectively performed QFR analysis in a total of 456 patients that underwent optical coherence tomography (OCT)-guided PCI at 5 Japanese institutions from 2010 to 2020. The primary endpoint was target vessel failure (TVF), defined as a composite of cardiac death, target vessel-related myocardial infarction and ischaemia-driven target vessel revascularisation. Following the exclusion of some patients, mainly because of suboptimal image quality for QFR and/or OCT analysis, a total of 298 patients were included for the final analyses. In the median follow-up period of 999 days, the presence of thin-cap fibroatheroma (TCFA) in non-culprit segments (NCS) (hazard ratio [HR] 3.47, 95% confidence interval [CI]: 1.46-8.24), high ΔQFR in the NCS (HR 1.15, 95% CI: 1.10-1.21) and low-post PCI QFR (HR 0.49, 95% CI: 0.39-0.62) were independently associated with TVF. The integration of TCFA and post-PCI QFR into models with traditional cardiac risk factors improved the discrimination ability.

The study provides useful insight into the value of morphofunctional assessment in the residual stenosis of the target vessel and suggests the need for improving the treatment strategy in ACS patients. However, the study did not evaluate non-culprit vessels. Furthermore, the applied models are potentially overfitted because (1) cutoffs for QFR and ΔQFR were derived from the same sample, (2) no cross-validation was performed, and (3) several important clinical and procedural characteristics (e.g., age, sex, post-dilation, residual % diameter stenosis [DS], irregular protrusion, malapposition) were not adjusted for because they were not judged statistically significant during univariate analyses. The overall event numbers are small and thus limit the generalisability of the findings (e.g., n=7-8 in groups with TCFA and QFR <0.88 or ΔQFR>0.046 in non-culprit segments).

The study adds to the accumulating evidence underlying an additive value of functional and morphological assessment of coronary lesions. Artificial intelligence is now applied to enable fast morphofunctional assessment from OCT or merely angiographic images67. It is expected that the diagnostic performance of imaging in the catheterisation laboratory will continue to improve in the coming years and ultimately translate into better patient care.

Conflict of interest statement

S. Tu is the cofounder of, has received research grants from, and has been a consultant for Pulse Medical. J. Westra has no conflicts of interest to declare.


References

Volume 20 Number 15
Aug 5, 2024
Volume 20 Number 15
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV15I2A26 Jun 20, 2019
FFR-guided PCI in STEMI
Nishi T and Fearon W
free

Editorial

10.4244/EIJ-E-25-00001 Feb 3, 2025
The pressure wire holds its ground: the debacle of QFR
Collet C et al
free

10.4244/EIJV15I15A240 Feb 7, 2020
How I became an FFR believer
Park S and Ahn J
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00064 Jul 20, 2018
Pressure wire compared to microcatheter sensing for coronary fractional flow reserve: the PERFORM study
Ali ZA et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00238 Feb 2, 2018
Pressure wire versus microcatheter for FFR measurement: a head-to-head comparison
Pouillot C et al
free
Trending articles
69.996

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
59.65

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
57.6

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
15.85

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
How is the diagnostic performance of imaging in the catheterization laboratory expected to improve in the coming years?
What are the conflicts of interest declared by the authors?
How do the findings of this study compare to previous research on the topic?
What are the potential future directions for research in this area?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved